Farmasian teknologian ja biofarmasian laitos
Department of Pharmaceutics

Julkaisut 1999
Publications 1999

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Antopolsky M et al. Peptide-oligonucleotide phosphorothioate conjugates with membrane translocation and nuclear localization properties.
2 Auriola S et al. Analysis of adenine nucleotide containing metabolite of clodronate using ion pair HPLC-ESI-MS.
3 Benford HL et al. Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs.
4 Cohen H et al. Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1)-a novel bisphosphonate.
5 Kanerva H. Pharmacokinetic Studies on Deramciclane.
6 Kanerva H et al. The single dose pharmacokinetics and safety of deramciclane in healthy male volunteers.
7 Kanerva H et al. Pharmacokinetics and safety of deramciclane during multiple oral dosing.
8 Kirjavainen M. A Mechanistic Evaluation of Liposome-Enhanced Percutaneous Permeation of Drugs.
9 Kirjavainen M, Mönkkönen J. Liposomit iholääkinnässä ja kosmetiikassa.
10 Kirjavainen M et al. Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers.
11 Kirjavainen M et al. Liposome-skin interactions and their effects on the skin permeation of drugs.
12 Makkonen N et al. Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite.
13 Mönkkönen J. Farmaseuttista kielenhuoltoa.
14 Mönkkönen J et al. Effects of bisphosphonates on the inflammatory processes of activated macrophages.
15 Pate DW et al., inventor. Anandamide analog compositions and method of treating intraocular hypertension using same.
16 Qu Q et al. Conditioned medium of estrogen-treated osteoblasts inhibits osteoclast maturation and function in vitro.
17 Rogers MJ et al. Molecular mechanisms of action of bisphosphonates.
18 Ruponen M et al. Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies.
19 Savolainen J et al. Coadministration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms.
20 Stensrud G et al. Toxicity of gamma irradiated liposomes. 2. In vitro effects on cells in culture.
21 Stensrud G et al. Toxicity of gamma irradiated liposomes. 1. In vitro interactions with blood components.
22 Sueyoshi T et al. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene.
23 Suhonen TM et al. Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations.
24 Tarvainen T et al. Drug release from cation exchange membrane in rabbit eye.
25 Tarvainen T et al. Drug release from a porous ion-exchange membrane in vitro.
26 Turunen MP et al. Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes.
27 Ylitalo P et al. Comparison of pharmacokinetics of clodronate after single and repeated doses.
28 Åkerman S. Temperature-, pH- and Ionic Strength-Responsive Grafted Polymer Membranes for Pharmaceutical Applications.
29 Åkerman S et al. Influence of ionic strength on drug adsorption onto and release from a poly(acrylic acid) grafted poly(vinylidene fluoride) membrane.
30 Åkerman S et al. Adsorption of drugs onto a poly(acrylic acid) grafted cation-exchange membrane.
31 Åkerman S et al. Adsorption of drugs onto a cation exchange membrane.

Farmasian teknologian ja biofarmasian laitos Department of Pharmaceutics
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008